GSK offloads over 5% stake in HUL via bulk deals

Mumbai: GlaxoSmithKline(GSK) and Horlicks will sell up to $3.4 billion (Rs 26,090 crore) worth of Hindustan Unilever shares through what could be India’s biggest secondary market block trades on Thursday, with the British drugmaker looking to monetise about 5.7 per cent of HUL stock it had got after last year’s merger of GSK Consumer Healthcare and the country’s most valuable FMCG company.